Our clients say it best. Read what they have to say about their experiences with Noble Financial Capital Markets and what differs us from the mainstream investment banks.

Phil Calamia KEYW Holding


"Noble is a long-term player with people who understand the importance of building solid relationships with issuers. They’re responsive, proactive, insightful and have a depth of experience that has been invaluable in the growth of our company. Perhaps what’s appreciated most is that Noble is not driven solely by transactions and that they take a personal interest in the success of KEYW."

KEYW provides highly specialized, mission-critical cybersecurity and geospatial intelligence solutions to U.S.Government, intelligence and national security agencies as well as in the case of its cybersecurity solutions to commercial customers.

Visit the website

Anthony Giovinazzo Cynapsus Therapeutics


"We began working with Noble Life Science Partners in 2013 due to their expertise in research, investment and merchant banking with specialty pharmaceutical companies such as Cynapsus. Noble took the time to understand our unique product offering as it relates to patients affected by OFF episodes associated with Parkinson’s disease. They assisted us in effectively communicating our story to some of Wall Street’s most respected healthcare institutional investors which resulted in a transformative financing for our company. We view Noble as a trusted advisor who has worked tirelessly to help Cynapsus and the patients we intend to serve."

Cynapsus Therapeutics is a clinical-stage, specialty pharmaceutical company developing a convenient and easy to use sublingual thin film strip to manage OFF episodes associated with Parkinson’s disease. Their lead drug candidate, APL-130277, is an easy-to-administer, fast-acting reformulation of apomorphine, which is the only approved acute drug (in the United States, Europe, Japan, and other countries) to rescue patients from OFF episodes associated with Parkinson’s disease.

Visit the website

Joel Primus Naked Brand Group


"We were introduced to Noble through attending their 2014 Annual Conference. We were below the market cap threshold to get noticed so they encouraged us to provide samples of our product to all [men] at the event; which we did. Our room was packed and so was our schedule of private meetings - the most important of which was with Nico. It was transformative and I’m not sure where we would be without Noble. We now have the funding we needed to take the company to the next level and the passionate support of a trusted financial partner."

Established in 2010 by founder Joel Primus in Vancouver, Naked is a lifestyle brand for both women and men; the men's line of underwear is available now with the women’s intimate apparel, sleepwear and loungewear being shipped to stores in Fall 2015. Naked has future plans to expand into other apparel and product categories that exemplify the mission of the brand, such as activewear, swimwear, sportswear.

Visit the website

Collin Jones Cumulus Media


"Before giving advice, Noble gains a thorough understanding of the company. Michael and his associates have been extremely perceptive in recognizing the needs of Cumulus. The depth of financial and sector experience, results in a very effective relationship. But what really stands out, is their passion for the job at hand. They take a personal stake in their role as financial advisors and throughout the investment banking process."

Cumulus Media, Inc., a radio broadcasting company, engages in the acquisition, operation, and development of commercial radio stations in mid-size radio markets in the United States. It owns and operates FM and AM radio station clusters that serve mid-sized markets. Cumulus Media, Inc. was founded in 1997 and is based in Atlanta, Georgia.

Visit the website

Elias Janetis / Rob Flippo MobileHelp


"Noble has been with us right from the beginning. Before we had a single client. They shared our vision immediately and took an active role in our development at all levels. Noble has helped us raise the money needed to fuel our growth, has invested directly and has even helped us manage the company. Nico has recommended board members and sits on the board himself. If you are looking for a no-nonsense firm that is straight-to-the-point and delivers what it promises, then your search stops at Noble."

MobileHelp is America's leading provider of M-PERS (Mobile-Personal Emergency Response System) technology. Based in Boca Raton, Florida, MobileHelp services clients in all 50 states. MobileHelp develops and distributes market leading products such as DUO, the first fully integrated medical alert system with GSM/GPS technology, SOLO, an innovative alert solution for people without home telephone lines and Classic Help, a traditional Medical Alert System.

Visit the website

David Wolfin Avino Silver & Gold


"Obviously Noble gets paid for their investment banking and advisory services. Never once do you feel like they are in it for the fees. Other intermediaries could learn from Noble’s professionalism, integrity and commitment to the process. They are patient and dig deep to make sure the investors are a good long-term fit for us. And because of this, Noble has become a long-term, trusted financial advisor to our company."

Avino Silver & Gold Mines Ltd. engages in the acquisition, exploration, development, production, and sale of mineral properties in Canada and Mexico. It primarily explores for gold, silver, copper, zinc, and lead deposits. Avino Silver & Gold Mines Ltd. was founded in 1968 and is headquartered in Vancouver, Canada.

Visit the website

Robert Finizio TherapeuticsMD


'We began working with Noble Life Science Partners in 2008 during our inception to assist us in raising capital and advise us on various aspects of our corporate planning. Over the years Noble has supported us in our company’s growth through value-added advice and services. We view Noble as a trusted long-term advisor and would recommend them wholeheartedly.'

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands.

More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.

Frederick Sancilio Sancilio & Company


"I began working with Noble Life Science Partners in 2011 through their work with a company we formulated products for. After several years of working together, I joined Noble's Scientific Advisory Board ("SAB") and also engaged Noble as my investment banker for our private placement in 2014. Noble effectively executed a robust road show and was successful in closing the transaction with several prominent healthcare institutional investors. Sancilio and Company has also joined forces with Noble on several fronts including new company formation and the advancement of the Life Sciences Industry in South Florida. I view Noble as an emerging premier life sciences investment and merchant bank with a value-added approach for its clients."

Sancilio and Company, Inc. ("SCI") is a fully integrated specialty pharmaceutical company engaged in the development, commercialization, and manufacturing of branded prescription, over-the-counter (“OTC”) and generic prescription pharmaceutical products. We leverage our formulation expertise and proprietary Advanced Lipid Technology™ (“ALT”) platform to develop, collaboratively with contract services clients and on our own, products intended to address the unmet medical needs of patients in the therapeutic areas of lipid disorders, cardiovascular disease, liver disease, pancreas-related disease, metabolic diseases, and endocrine disorders - especially those that are a result of reversible imbalances of essential lipophilic substances that impact the structure and function of the body. We also have significant expertise related to soft gelatin encapsulation, which offers unique advantages as a high barrier dosage form. We have a diversified product portfolio of established branded pharmaceutical products and product candidates. Our current marketable pharmaceutical products are OTC and behind-the-counter lines of highly concentrated omega-3 essential fatty acids products designed to improve cardiovascular and metabolic health under the brand Ocean Blue®, and generic prescription drug products in the dental and women’s health markets./i]

Visit the website